Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Wangen im Allgaeu

2 clinical trials in Wangen im Allgaeu, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Wangen im Allgaeu at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Wangen im Allgaeu

Open in trial search

Type 2 diabetes mellitus

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Non-small cell lung cancer+1

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Wangen im Allgaeu

What the registry says about research in the country

01 Wangen im Allgaeu
Oncology – Non‑Small Cell Lung Cancer
Researchers in Wangen im Allgaeu are conducting a trial to compare the new therapy pumitamig with the established immunotherapy pembrolizumab in patients with advanced disease. The study aims to determine whether the investigational drug can better control tumor growth and extend survival. Evaluation of cancer control efficacy Measurement of overall survival benefits Inclusion of participants with high PD‑L1 expression Comparison with standard immunotherapy outcomes This effort highlights the city’s focus on innovative cancer research within the neoplasm therapeutic area.
Metabolic Disease – Type 2 Diabetes Mellitus
A second trial in Wangen im Allgaeu examines the glycemic impact of elecoglipron versus the widely used oral agent semaglutide. The objective is to assess which medication provides superior blood‑sugar control for adults living with type 2 diabetes. Direct comparison of glycemic efficacy Monitoring of safety and tolerability Assessment of patient‑reported outcomes Evaluation of long‑term metabolic benefits This study underscores the city’s commitment to advancing treatments for metabolic and nutritional disorders.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.